"At The MHP Radiation Oncology Institute - part of Genesiscare network, we offer multidisciplinary personalized cancer treatments based on individual patient needs. From the latest techniques and cutting-edge technologies to our highly skilled team of physicians, we provide world-class cancer care close to home."

During the past decade, 21st Century Oncology-Pontiac conducted 124 clinical trials. In the 10-year time frame, 124 clinical trials started and 31 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 57 clinical trials started and 31 clinical trials were completed. i.e. 54.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "21st Century Oncology-Pontiac" #1 sponsor was "National Cancer Institute (NCI)" with 67 trials, followed by "Alliance for Clinical Trials in Oncology" with 27 trials sponsored, "SWOG Cancer Research Network" with 21 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 12 trials sponsored and "NRG Oncology" with 12 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "21st Century Oncology-Pontiac" #1 collaborator was "National Cancer Institute (NCI)" with 74 trials as a collaborator, "NRG Oncology" with 11 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "21st Century Oncology-Pontiac" are "Stage IV Lung Cancer AJCC v8" (9 trials), "Invasive Breast Carcinoma" (6 trials), "Recurrent Lung Non-Small Cell Carcinoma" (6 trials), "Stage IVA Lung Cancer AJCC v8" (6 trials) and "Stage IVB Lung Cancer AJCC v8" (6 trials). Many other conditions were trialed in "21st Century Oncology-Pontiac" in a lesser frequency.

Most popular intervention types in "21st Century Oncology-Pontiac" are "Drug" (113 trials), "Other" (84 trials), "Biological" (52 trials), "Procedure" (41 trials) and "Radiation" (23 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (42 trials), "Laboratory Biomarker Analysis" (30 trials), "Questionnaire Administration" (28 trials), "Biospecimen Collection" (24 trials) and "Computed Tomography" (23 trials). Other intervention names were less common.

The vast majority of trials in "21st Century Oncology-Pontiac" are 122 trials for "All" genders, 15 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "21st Century Oncology-Pontiac". undefined are not yet recruiting, 56 are recruiting, 63 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in 21st Century Oncology-Pontiac, 6 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in 21st Century Oncology-Pontiac, 2 "Phase 1" clinical trials were conducted, 74 "Phase 2" clinical trials and 73 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".